GRANT Guide

Home » Grants » 2022 SITC-Natera ctDNA in Immunotherapy Response Monitoring Fellowship and Technology Award (worldwide)

This opportunity is currently closed.

Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.

2022 SITC-Natera ctDNA in Immunotherapy Response Monitoring Fellowship and Technology Award (worldwide)

The 2022 SITC-Natera ctDNA in Immunotherapy Response Monitoring Fellowship and Technology Award from the Society for Immunotherapy of Cancer (SITC) with funding from Natera, supports a postdoctoral researcher, resident, research scientist, or comparable position, working on ctDNA testing for molecular residual disease. Applicants must be a member of the SITC and hold an MD, PhD or MD/PhD degree. Applications are open to candidates worldwide. The fellowship provides funding of 40,000 USD, access to Natera´s Signatera™ testing technology, plus financial support to attend SITC´s 37th Annual Meeting. Applications close on April 5, 2022.

Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.